Differential diagnosis and mutation stratification of desmoid-type fibromatosis on MRI using radiomics

Journal Article (2020)
Authors

Milea J.M. Timbergen (Erasmus MC)

Martijn P.A. Starmans (Erasmus MC, Student TU Delft)

Guillaume A. Padmos (Erasmus MC)

Dirk Grünhagen (Erasmus MC)

Geert J.L.H. van Leenders (Erasmus MC)

D. F. Hanff (Erasmus MC)

WJ Niessen (ImPhys/Medical Imaging, ImPhys/Computational Imaging, Erasmus MC)

S. Klein (Erasmus MC)

Jacob J. Visser (Erasmus MC)

G.B. More Authors (External organisation)

Research Group
ImPhys/Medical Imaging
Copyright
© 2020 Milea J.M. Timbergen, Martijn P.A. Starmans, Guillaume A. Padmos, Dirk J. Grünhagen, Geert J.L.H. van Leenders, D. F. Hanff, W.J. Niessen, S. Klein, J.J. Visser, More Authors
To reference this document use:
https://doi.org/10.1016/j.ejrad.2020.109266
More Info
expand_more
Publication Year
2020
Language
English
Copyright
© 2020 Milea J.M. Timbergen, Martijn P.A. Starmans, Guillaume A. Padmos, Dirk J. Grünhagen, Geert J.L.H. van Leenders, D. F. Hanff, W.J. Niessen, S. Klein, J.J. Visser, More Authors
Research Group
ImPhys/Medical Imaging
Volume number
131
DOI:
https://doi.org/10.1016/j.ejrad.2020.109266
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Purpose: Diagnosing desmoid-type fibromatosis (DTF) requires an invasive tissue biopsy with β-catenin staining and CTNNB1 mutational analysis, and is challenging due to its rarity. The aim of this study was to evaluate radiomics for distinguishing DTF from soft tissue sarcomas (STS), and in DTF, for predicting the CTNNB1 mutation types. Methods: Patients with histologically confirmed extremity STS (non-DTF) or DTF and at least a pretreatment T1-weighted (T1w) MRI scan were retrospectively included. Tumors were semi-automatically annotated on the T1w scans, from which 411 features were extracted. Prediction models were created using a combination of various machine learning approaches. Evaluation was performed through a 100x random-split cross-validation. The model for DTF vs. non-DTF was compared to classification by two radiologists on a location matched subset. Results: The data included 203 patients (72 DTF, 131 STS). The T1w radiomics model showed a mean AUC of 0.79 on the full dataset. Addition of T2w or T1w post-contrast scans did not improve the performance. On the location matched cohort, the T1w model had a mean AUC of 0.88 while the radiologists had an AUC of 0.80 and 0.88, respectively. For the prediction of the CTNNB1 mutation types (S45 F, T41A and wild-type), the T1w model showed an AUC of 0.61, 0.56, and 0.74. Conclusions: Our radiomics model was able to distinguish DTF from STS with high accuracy similar to two radiologists, but was not able to predict the CTNNB1 mutation status.